No Stomach For Cancer – Scientific Advisory Council
Scientific Advisory Council members are highly accomplished professionals with medical and/or research background, who provide expert and comprehensive perspectives as well as guidance to No Stomach For Cancer, Inc. with regard to technical, medical, and research related topics. The Council provides knowledge and support that are critical in furthering our Mission.
Fátima Carneiro, MD, PhD
Professor
Institute of Molecular Pathology and Immunology of Porto University (IPATIMUP)
and Faculty of Medicine/Hospital S. João
Porto, Portugal
Dr. Carneiro is Professor of Anatomic Pathology at the Porto University, Department Head of Anatomic Pathology at the Hospital S. Joao in Port, and Senior Investigator for IPATIMUP. She is president-elect of the European Society of Pathology, and a long-standing member of the Steering Group of the International Gastric Cancer Linkage Consortium. Dr. Carneiro is also the Coordinator of the Portuguese Network of Tumor Banks.
Daniel C. Chung, MD
Clinical Chief, Gastrointestinal Unit
Director, GI Cancer Genetics Program, Cancer Center
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA
Parry Guilford, BSc, MSc, PhD
Associate Professor
Cancer Genetics Laboratory
University of Otago
Dunedin, New Zealand
Associate Professor Parry Guilford is a principal Investigator in the Cancer Genetics Laboratory, University of Otago, Dunedin, New Zealand, and the Chief Scientific Officer and co-founder of Pacific Edge Biotechnology Ltd. He completed his MSc at Otago in 1983, and his PhD at Cambridge University in 1989. During postdoctoral studies at the Paasteur Institute in Paris, he led a team that localised the first genes for non-syndromic recessive deafness. His current research interests include the genetics of inherited cancers, in particular stomach cancer, and the application of genetics to the diagnosis and management of cancer. He has worked for the last 10 years with the Maori tribe Ngai te Rangi researching the causes and treatment of inherited stomach cancer.
David G. Huntsman, MD, FRCPC, FCCMG
Interim Director, OvCaRe BC
Professor, Department of Pathology and Lab Medicine, UBC
Medical Director, Centre for Translational and Applied Genomics, BC Cancer Agency
Vancouver, BC
Dr. David Huntsman is Professor of Pathology and Laboratory Medicine at The University of British Columbia (UBC), a Staff Pathologist at the BC Cancer Agency (BCCA), and a Consulting Pathologist at the Vancouver General Hospital.
Dr. Huntsman attended medical school at Memorial University of Newfoundland from 1984–88 and after completing a rotating internship, practiced family medicine in Labrador for two years. Following his experience in family medicine, he entered and completed a pathology residency and trained in clinical molecular genetics at UBC and subsequently studied cancer genetics at Cambridge University, UK.
Dr. Huntsman is currently the Interim Director of the BC multidisciplinary ovarian cancer research team (OvCaRe), Medical Director of the Centre for Translational and Applied Genomics (CTAG) at the BCCA, co-Director of the Genetic Pathology Evaluation Centre (GPEC) at the Jack Bell Research Centre, VGH, and Associate Director of the Hereditary Cancer Program (HCP) at the BC Cancer Agency.
Dr. Huntsman has active research programs in hereditary gastric cancer as well as in the development of predictive and prognostic tissue based cancer biomarkers of a wide variety of tumor types. As collaboration is critical in his field, Dr. Huntsman happily leads and engages in a wide number of multidisciplinary research groups.
Pardeep Kaurah, MSc, CCGC
Research Genetic Counsellor
Hereditary Cancer Program
BC Cancer Agency
Vancouver, BC
Pardeep Kaurah is a research genetic counselor at the Hereditary Cancer Program at the BC Cancer Agency in Vancouver. She received her master’s degree in Genetic Counseling from McGill University in Montreal, Quebec in 1995. She has been the research clinical coordinator for the Hereditary Diffuse Gastric Cancer Study in BC since 2002. She is also currently doing her doctoral degree which involves documenting and describing the clinical outcomes and quality of life in individuals who have had prophylactic total gastrectomy.
Gregory Y. Lauwers, MD
Associate Professor of Pathology, Harvard Medical School
Director of Gastrointestinal Pathology
Massachusetts General Hospital
Boston, MA
Devanshi Patel, MS, CGC
Senior Genetic Counselor
Massachusetts General Hospital Cancer Center
Boston, MA
Devanshi Patel is a licensed genetic counselor who earned her master’s degree in Genetic Counseling from Brandeis University in Massachusetts. After graduating she joined the cardiology department at Children’s Hospital Boston where she gained experience working with pediatric, adult and prenatal cardiovascular genetics patients in both clinical and research capacities. She then went on to join Center for Medical Genetics at Evanston Northwestern Healthcare (now Northshore University Healthsystem) in Illinois where was involved in providing clinical care for adult patients. She was also the research coordinator for the Pancreatic Cancer Family Registry. In 2005, she joined the Massachusetts General Hospital Center for Cancer Risk Assessment. Devanshi provides cancer risk assessment and genetic counseling services to patients within the diverse clinical programs at the MGH Cancer Center. Her activities also include educating health-care providers and the lay-public in genetics, student supervision and training. Devanshi’s primary interests lie in patient care and education outreach programs that facilitate the integration of genetics into medical care.
Raquel Seruca, MD, PhD
Group Leader of Cancer Genetics Group
Institute of Molecular Pathology and Immunology of Porto University (IPATIMUP)
Affiliated Professor, Medical Faculty of Porto University
Portugal
Dr. Seruca serves as group leader for IPATIMUP as well as Professor on the Medical Faculty at Porto University. She holds memberships in numerous scientific committees throughout Europe, as well as long-standing membership in the International Gastric Cancer Linkage Consortium.
Current research interests for Dr. Seruca include molecular mechanisms of cancer invasion, especially E-cadherin and P-cadherin, as well as clinical aspects and cytomolecular genetics of gastrointestinal cancer in both sporadic and hereditary forms. She has co-authored more than 160 publications in international journals and three book chapters.
Donna Walsh, MS, RD, CSO, LD
Nutrition & Wellness Coordinator
Harold Alfond Center for Cancer Care
Augusta, ME
Donna Walsh is a Registered Dietitian with over 30 years of experience in the field of nutrition and health education. She provides nutrition services for oncology patients at the Harold Alfond Center for Cancer Care in Augusta. In addition, Donna also provides education and classes on nutrition and cancer prevention throughout the central Maine area.
Donna’s academic background includes degrees in Nutrition and Dietetics and Master’s in Public Health with emphasis on Community Health Education. She is a Certified Specialist in Oncology Nutrition by the Commission on Dietetic Registration.
Sam S. Yoon, MD
Division of Surgical Oncology
Massachusetts General Hospital
Boston, MA
Sam S. Yoon, MD, is a surgical oncologist at the Massachusetts General Hospital Cancer Center and an Assistant Professor of Surgery at the Harvard Medical School.
Dr. Yoon specializes in the treatment of patients with upper gastrointestinal malignancies including gastric cancer as well as patients with soft tissue sarcomas. Dr. Yoon is a graduate of Harvard University and received his medical degree from the University of California at San Diego. He completed his residency in general surgery at Massachusetts General Hospital and his fellowship in surgical oncology at Memorial Sloan-Kettering Cancer Center.
Dr. Yoon’s clinical research focuses on the development of novel treatment strategies for patients with gastric cancer and sarcomas. Dr. Yoon received additional training in gastric cancer surgery at Seoul National University Hospital, which performs nearly 1000 gastric cancer surgeries per year, and has published several articles on prophylactic total gastrectomy for patients at risk for hereditary diffuse gastric cancer. Overall, he has published over 50 original research and review articles related to gastric cancer, sarcomas, and tumor angiogenesis in journals such as the New England Journal of Medicine and the Annals of Surgery.
